A
Anna Serradesanferm
Researcher at University of Barcelona
Publications - 28
Citations - 1477
Anna Serradesanferm is an academic researcher from University of Barcelona. The author has contributed to research in topics: Colonoscopy & Colorectal cancer. The author has an hindex of 15, co-authored 26 publications receiving 1292 citations.
Papers
More filters
Journal ArticleDOI
Programas de cribado del cáncer colorrectal en la población de riesgo medio en la Unión Europea y España
Jaume Grau,Anna Serradesanferm,Sandra Polbach,Alberto L. García-Basteiro,Antoni Trilla,Antoni Castells +5 more
TL;DR: Hay un amplio consenso internacional sobre la necesidad del cribado del cancer colorrectal en varones y mujeres con edad igual o superior a 50 anos, sin antecedentes personales ni familiares de adenomas ni CCR.
Journal ArticleDOI
Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.
Antoni Castells,Enrique Quintero,Cristina Alvarez,Luis Bujanda,Joaquín Cubiella,Dolores Salas,Angel Lanas,Fernando Carballo,Juan Diego Morillas,Cristina Hernández,Rodrigo Jover,Elizabeth Hijona,Isabel Portillo,José María Enríquez Navascues,Vicent Hernandez,Alfonso Martínez-Turnes,Carlos Menéndez-Villalva,Carmen González-Mao,Teresa Sala,Marta Ponce,Mercedes Andrés,Gloria Teruel,Antonio Peris,Federico Sopena,Francisca González-Rubio,Agustín Seoane-Urgorri,Jaume Grau,Anna Serradesanferm,Angels Pozo,Maria Pellise,Francesc Balaguer,Akiko Ono,José Cruzado,Francisco Pérez-Riquelme,Inmaculada Alonso-Abreu,Marta Carrillo-Palau,Mariola de la Vega-Prieto,Rosario Iglesias,Javier Amador,José Manuel Blanco,Rocío Sastre,Juan Ferrándiz,Ma José González-Hernández,Montserrat Andreu,Xavier Bessa,Alberto Moya-Calvo,Mónica Polo-Tomás,Maria Pilar Roncales,Pilar Sebastian-Martínez,María Ángeles Valencia-Doblas,Nieves Valero-Capilla,M. E. Alkiza,Jone M. Altzibar,Pilar Amiano,Juan Arenas,Edurne Artiñano,Angel Cosme,Isabel Egitegi,Kepa Elorriaga,José Luis Elósegui,José María Enríquez-Navascués,Cristina Erce,Inés Gil,María A. Gutierrez-Stampa,Marta Herreros,Mariluz Jaúregui,Eva Laredo,Roberto Martínez,Maria J. Mitxelena,Isabel Montalvo,Carlos Placer,Cristina Sarasqueta,Onofre Alarcón,María Luisa Díez-Fuentes,Antonio Z. Gimeno-García,Yanira González-Méndez,Manuel Hernández-Guerra,Renata Linertová,David Nicolás-Pérez,Juana María Reyes-Melián,Josep M. Augé,Mercè Barau,Felipe Bory,Andrea Burón,Xavier Castells,Mercè Comas,Miriam Cuatrecasas,Maria Estrada,Olga Ferrer,Imma Garrell,Rafael Guayta,María López-Cerón,Francesc Macià,Leticia Moreira,Teresa Ocaña,Mercè Piracés,Sandra Polbach,Marc Puigvehí,Cristina Rodríguez,Maria Sala,Agustín Seoane,Judith Sivilla,Antoni Trilla,Mª Belén Aguado,Susana Aldecoa,Raquel Almazán,Ana Alonso,Inés Castro,Estela Cid,Lucía Cid,Joan Clofent,Mª Luisa de Castro,Pamela Estévez,Ana Belén Fernández,Mª Dolores González,S. González,Mª Carmen González-Mao,Begoña Iglesias,Felipe Iglesias,Pilar Iglesias,Ángeles López-Martínez,Ramiro Macenlle,Alfonso Martínez,David Martínez,Carlos Menéndez,Carmen Méndez,Jose Antonio Hermo,Isabel Pérez,Carmen Portasany,Mar Rionda,Concepción Rivera,Benito Rodríguez,Rosa Rodríguez,Manuel Diaz Rubio,María Isolina Santiago,Miriam Vázquez,José Ángel Vázquez,Pablo Vega,Mª Carmen Vidal,Raquel Zubizarreta +139 more
TL;DR: Sigmoidoscopy and FIT have similar limitations in detecting advanced proximal neoplasms, which depend on patients' characteristics; sigmoidsoscopy underperforms for women 50-59 years old.
Journal ArticleDOI
Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program.
Liseth Rivero-Sánchez,Jaume Grau,Josep M. Augé,Lorena Moreno,Angels Pozo,Anna Serradesanferm,Mireia Díaz,Sabela Carballal,Ariadna Sánchez,Leticia Moreira,Francesc Balaguer,Maria Pellise,Antoni Castells +12 more
TL;DR: The very low incidence of post-colonoscopy colorectal cancer (PCCRC) and characteristics of PCCRC observed in participants from the first round of a CRC screening program reinforce the concept that, although a positive FIT preselects high risk individuals, a high quality colonoscopy is the paramount factor in preventing P CCRC.
Journal ArticleDOI
Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test–Based Screening for Colorectal Cancer
Saray Duran-Sanchon,Lorena Moreno,Javier Gómez-Matas,Josep M. Augé,Miquel Serra-Burriel,Miriam Cuatrecasas,Leticia Moreira,Anna Serradesanferm,Angels Pozo,Jaume Grau,Maria Pellise,Meritxell Gironella,Antoni Castells +12 more
TL;DR: An algorithm based on fecal levels of 2 miRNAs and hemoglobin, patient age and sex (miRFec) differentiated patients with CRC from those with non-advanced adenomas or normal colonoscopy with an area under the receiver operating characteristic curve value of 90% and avoided 34% of colonoscopies.
Journal ArticleDOI
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: A prospective non-randomized controlled trial
C Rodríguez de Miguel,Anna Serradesanferm,María López-Cerón,Sabela Carballal,Angels Pozo,Francesc Balaguer,Andrés Cárdenas,Gloria Fernández-Esparrach,Angels Ginès,Begoña González-Suárez,Leticia Moreira,Ingrid Ordás,Elena Ricart,Oriol Sendino,Eva C. Vaquero,M. Ubré,S. del Manzano,Jaume Grau,Joan Llach,Antoni Castells,Maria Pellise +20 more
TL;DR: In early morning colonoscopies, ascPEG-2L appears to be the best option, especially when administered in a split-dose, especially with the split dose than with other doses.